Get Real Time Here
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
HOOKIPA Pharma Stock (NASDAQ:HOOK), Quotes and News Summary
HOOKIPA Pharma Stock (NASDAQ: HOOK) stock price, news, charts, stock research, profile.
| Open0.600 | Close- |
| Vol / Avg.259.164K / 472.799K | Mkt Cap49.170M |
| Day Range0.550 - 0.605 | 52 Wk Range0.590 - 2.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.210 | -0.220 | -0.0100 | ||||
| REV | 4.870M | 2.679M | -2.191M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-06 | Truist Securities | Asthika Goonewardene | Reiterates | BuyBuy | Maintains | - | 4.00 |
| 2023-08-11 | HC Wainwright & Co. | Arthur He | Maintains | BuyBuy | Lowers | 8.00 | 6.50 |
| 2023-06-30 | RBC Capital | Brian Abrahams | Reiterates | OutperformOutperform | Maintains | - | 7.00 |
| 2023-06-05 | Morgan Stanley | Vikram Purohit | Maintains | Equal-WeightEqual-Weight | Raises | 2.00 | 2.25 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HOOK | HOOKIPA Pharma | -2.43% | 49.2M |
| OTLK | Outlook Therapeutics | 1.01% | 54.9M |
| AGLE | Aeglea BioTherapeutics | -4.26% | 46M |
| CRIS | Curis | -4.32% | 50.7M |
| INTS | Intensity Therapeutics | 8.15% | 54.5M |
How do I buy HOOKIPA Pharma (HOOK) stock?
You can purchase shares of HOOKIPA Pharma (NASDAQ: HOOK) through any online brokerage.
Who are HOOKIPA Pharma's (HOOK) competitors?
Other companies in HOOKIPA Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Aeglea BioTherapeutics (NASDAQ:AGLE), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the target price for HOOKIPA Pharma (HOOK) stock?
The latest price target for HOOKIPA Pharma (NASDAQ: HOOK) was reported by Truist Securities on Wednesday, September 6, 2023. The analyst firm set a price target for 4.00 expecting HOOK to rise to within 12 months (a possible 582.94% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for HOOKIPA Pharma (HOOK)?
The stock price for HOOKIPA Pharma (NASDAQ: HOOK) is $0.5857 last updated Today at September 25, 2023 at 7:15 PM UTC.
Does HOOKIPA Pharma (HOOK) pay a dividend?
There is no dividend information for HOOKIPA Pharma.
When is HOOKIPA Pharma (NASDAQ:HOOK) reporting earnings?
HOOKIPA Pharma’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is HOOKIPA Pharma (HOOK) going to split?
There is no upcoming split for HOOKIPA Pharma.
What sector and industry does HOOKIPA Pharma (HOOK) operate in?
HOOKIPA Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.